Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00538733. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lympho
ClinicalTrials.gov study NCT02098109. IPD Sharing: NO. Countries: 1. Publications: 1.
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
ClinicalTrials.gov study NCT00869206. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01355705. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03761108. IPD Sharing: YES. Countries: 7. Publications: 2.
A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT02951819. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
ClinicalTrials.gov study NCT01402284. IPD Sharing: NO. Countries: 1. Publications: 7.
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00602641. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT04126200. IPD Sharing: YES. Countries: 15. Publications: 2.
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.
ClinicalTrials.gov study NCT00405756. IPD Sharing: Not stated. Countries: 22. Publications: 3.
A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy
ClinicalTrials.gov study NCT02755597. IPD Sharing: YES. Countries: 16. Publications: 2.
A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01421186. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01080391. IPD Sharing: Not stated. Countries: 20. Publications: 14.
Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma
ClinicalTrials.gov study NCT00743288. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03338972. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
ClinicalTrials.gov study NCT00790842. IPD Sharing: NO. Countries: 1. Publications: 1.
Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01794520. IPD Sharing: YES. Countries: 4. Publications: 2.
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT02603887. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00920556. IPD Sharing: YES. Countries: 2. Publications: 1.
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
ClinicalTrials.gov study NCT01109004. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.